The Sapienza University Mortality and Morbidity Events Rate (SUMMER) Study in Diabetes (SUMMER)
The Sapienza University Mortality and Morbidity Events Rate (SUMMER) Study in Diabetes: Identification of New Molecular Promoters of Mortality and Morbidity in Patients With Type 2 Diabetes Mellitus
Sponsor: Azienda Ospedaliera San Camillo Forlanini
Listed as NCT02311244, this observational or N/A phase trial focuses on Type 2 Diabetes Mellitus and remains completed. Sponsored by Azienda Ospedaliera San Camillo Forlanini, it has been updated 12 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2023 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Dec 2021 — Jun 2023 [monthly]
Recruiting
-
Oct 2021 — Dec 2021 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2018 — Nov 2020 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Ospedaliera San Camillo Forlanini
- Campus Bio-Medico University
- Casa Sollievo della Sofferenza IRCCS
- Ospedale Sandro Pertini, Roma
- University of Cagliari
- University of Roma La Sapienza
For direct contact, visit the study record on ClinicalTrials.gov .